13F HOLDINGS REPORT
Deep Track Capital, LP
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001856083-24-000007
Total Value
$3.15B
Positions
71
Other Managers
0
Confidential Omitted
No
Holdings (71)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARGENX SE | ARGX | 365,000 | $197.9M | 6.28% |
| 2 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 12,526,486 | $139.5M | 4.43% |
| 3 | GUARDANT HEALTH INC | GH | 6,000,560 | $137.7M | 4.37% |
| 4 | APELLIS PHARMACEUTICALS INC | APLS | 4,400,654 | $126.9M | 4.03% |
| 5 | IMMUNOVANT INC | IMVT | 4,347,464 | $123.9M | 3.93% |
| 6 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 3,843,900 | $123.2M | 3.91% |
| 7 | DYNE THERAPEUTICS INC | DYN | 3,282,000 | $117.9M | 3.74% |
| 8 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 1,600,693 | $117.1M | 3.72% |
| 9 | OCULAR THERAPEUTIX INC | OCUL | 12,721,460 | $110.7M | 3.51% |
| 10 | INTELLIA THERAPEUTICS INC | NTLA | 4,950,000 | $101.7M | 3.23% |
| 11 | ALKERMES PLC | ALKS | 3,500,000 | $98.0M | 3.11% |
| 12 | VERONA PHARMA PLC | 925050106 | 3,180,025 | $91.5M | 2.90% |
| 13 | IONIS PHARMACEUTICALS INC | IONS | 2,200,000 | $88.1M | 2.80% |
| 14 | NURIX THERAPEUTICS INC | NRIX | 3,868,104 | $86.9M | 2.76% |
| 15 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,750,945 | $85.3M | 2.71% |
| 16 | BICYCLE THERAPEUTICS PLC | BCYC | 3,548,001 | $80.3M | 2.55% |
| 17 | MBX BIOSCIENCES INC | MBX | 3,018,935 | $78.4M | 2.49% |
| 18 | AXSOME THERAPEUTICS INC | AXSM | 857,219 | $77.0M | 2.44% |
| 19 | PLIANT THERAPEUTICS INC | PLRX | 5,972,257 | $66.9M | 2.12% |
| 20 | APOGEE THERAPEUTICS INC | APGE | 1,000,000 | $58.7M | 1.86% |
| 21 | AUTOLUS THERAPEUTICS PLC | AUTL | 15,272,172 | $55.4M | 1.76% |
| 22 | STRUCTURE THERAPEUTICS INC | GPCR | 1,220,508 | $53.6M | 1.70% |
| 23 | OLEMA PHARMACEUTICALS INC | OLMA | 4,000,000 | $47.8M | 1.51% |
| 24 | TERNS PHARMACEUTICALS INC | TERN | 5,576,558 | $46.5M | 1.48% |
| 25 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 4,096,452 | $44.3M | 1.40% |
| 26 | ABIVAX SA | AAVXF | 3,579,209 | $41.2M | 1.31% |
| 27 | TG THERAPEUTICS INC | TGTX | 1,725,000 | $40.3M | 1.28% |
| 28 | MIND MEDICINE MINDMED INC | 60255C885 | 7,065,099 | $40.2M | 1.28% |
| 29 | KURA ONCOLOGY INC | KURA | 1,963,505 | $38.4M | 1.22% |
| 30 | GERON CORP | GERN | 7,575,049 | $34.4M | 1.09% |
| 31 | CYTOKINETICS INC | CYTK | 629,906 | $33.3M | 1.05% |
| 32 | ORUKA THERAPEUTICS INC | ORKA | 1,235,187 | $30.3M | 0.96% |
| 33 | ANI PHARMACEUTICALS INC | ANIP | 504,828 | $30.1M | 0.96% |
| 34 | SPYRE THERAPEUTICS INC | SYRE | 1,000,000 | $29.4M | 0.93% |
| 35 | EDGEWISE THERAPEUTICS INC | EWTX | 1,100,536 | $29.4M | 0.93% |
| 36 | KYMERA THERAPEUTICS INC | KYMR | 600,326 | $28.4M | 0.90% |
| 37 | KORRO BIO INC | KRRO | 850,000 | $28.4M | 0.90% |
| 38 | AVIDITY BIOSCIENCES INC | 05370A108 | 475,000 | $21.8M | 0.69% |
| 39 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1,350,000 | $21.6M | 0.68% |
| 40 | ALECTOR INC | ALEC | 4,631,998 | $21.6M | 0.68% |
| 41 | NEKTAR THERAPEUTICS | NKTR | 15,922,655 | $20.7M | 0.66% |
| 42 | 89BIO INC | 282559103 | 2,766,512 | $20.5M | 0.65% |
| 43 | BICARA THERAPEUTICS INC | BCAX | 796,852 | $20.3M | 0.64% |
| 44 | AKERO THERAPEUTICS INC | 00973Y108 | 689,784 | $19.8M | 0.63% |
| 45 | FATE THERAPEUTICS INC | FATE | 5,572,607 | $19.5M | 0.62% |
| 46 | SILENCE THERAPEUTICS PLC | SLNCF | 1,000,000 | $18.2M | 0.58% |
| 47 | AXSOME THERAPEUTICS INC | AXSM | 200,000 | $18.0M | 0.57% |
| 48 | ENGENE HOLDINGS INC | ENGNW | 2,607,633 | $17.2M | 0.55% |
| 49 | EDITAS MEDICINE INC | EDIT | 4,900,334 | $16.7M | 0.53% |
| 50 | XENCOR INC | XNCR | 800,000 | $16.1M | 0.51% |
| 51 | PYXIS ONCOLOGY INC | PYXS | 4,184,100 | $15.4M | 0.49% |
| 52 | CONTEXT THERAPEUTICS INC | CNTX | 7,419,355 | $14.5M | 0.46% |
| 53 | CYBIN INC | HELP | 1,529,987 | $13.6M | 0.43% |
| 54 | ZURA BIO LTD | ZURA | 3,283,783 | $13.3M | 0.42% |
| 55 | INVIVYD INC | IVVD | 10,953,937 | $11.2M | 0.35% |
| 56 | ELIEM THERAPEUTICS INC | CLYM | 2,169,143 | $11.0M | 0.35% |
| 57 | INOVIO PHARMACEUTICALS INC | INO | 1,804,366 | $10.4M | 0.33% |
| 58 | AVALO THERAPEUTICS INC | AVTX | 967,000 | $9.2M | 0.29% |
| 59 | NEUMORA THERAPEUTICS INC. | NMRA | 567,428 | $7.5M | 0.24% |
| 60 | TRAVERE THERAPEUTICS INC | TVTX | 531,857 | $7.4M | 0.24% |
| 61 | VIGIL NEUROSCIENCE INC | 92673K108 | 1,553,996 | $5.3M | 0.17% |
| 62 | REGULUS THERAPEUTICS INC | 75915K309 | 3,262,564 | $5.1M | 0.16% |
| 63 | ALLAKOS INC | 01671P100 | 5,000,000 | $3.3M | 0.10% |
| 64 | ALTO NEUROSCIENCE INC | ANRO | 219,648 | $2.5M | 0.08% |
| 65 | NEUMORA THERAPEUTICS INC. | NMRA | 180,500 | $2.4M | 0.08% |
| 66 | PROTHENA CORP PLC | PRTA | 140,000 | $2.3M | 0.07% |
| 67 | RELMADA THERAPEUTICS INC | RLMD | 674,833 | $2.2M | 0.07% |
| 68 | ALIGOS THERAPEUTICS INC | ALGS | 244,110 | $2.1M | 0.07% |
| 69 | SYROS PHARMACEUTICALS INC | 87184Q206 | 828,485 | $1.8M | 0.06% |
| 70 | METAGENOMI INC | MGX | 307,500 | $667,275 | 0.02% |
| 71 | SCHOLAR ROCK HLDG CORP | SRRK | 48,100 | $385,281 | 0.01% |